Year |
Citation |
Score |
2006 |
Kamboh MI, Minster RL, Kenney M, Ozturk A, Desai PP, Kammerer CM, DeKosky ST. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease. Neurobiology of Aging. 27: 1435-9. PMID 16137793 DOI: 10.1016/J.Neurobiolaging.2005.07.015 |
0.711 |
|
2005 |
Ozturk A, Desai PP, Minster RL, Dekosky ST, Kamboh MI. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease. Neurobiology of Aging. 26: 1161-5. PMID 15917099 DOI: 10.1016/J.Neurobiolaging.2004.11.001 |
0.701 |
|
2005 |
Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiology of Disease. 20: 574-82. PMID 15916898 DOI: 10.1016/J.Nbd.2005.04.012 |
0.558 |
|
2005 |
Desai P, Nebes R, DeKosky ST, Kamboh MI. Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression. Neuroscience Letters. 379: 229-34. PMID 15843069 DOI: 10.1016/J.Neulet.2005.01.008 |
0.622 |
|
2004 |
Desai P, Ganguli M, Nebes RD, DeKosky ST, Ilyas Kamboh M. P4-139 Lack of association between polymorphisms in the brain-derived neurotrophic factor (BDNF) and sporadic late-onset Alzheimer's disease in caucasians Neurobiology of Aging. 25: S515. DOI: 10.1016/S0197-4580(04)81697-X |
0.528 |
|
2004 |
Minster RL, Desai PP, Öztürk A, Chen Q, Ganguli M, Nebes RD, Reynolds CF, DeKosky ST, Ilyas Kamboh M. P4-131 Association of the APOE promoter polymorphisms with late-onset Alzheimer's disease Neurobiology of Aging. 25: S512-S513. DOI: 10.1016/S0197-4580(04)81689-0 |
0.696 |
|
2004 |
Ozturk A, Desai PP, Minster RL, Scott T, Kammerer CM, DeKosky ST, Kamboh MI. P4-078 Alpha-1 antichymotrypsin (ACT or serpina3) may affect age-at-onset of Alzheimer's disease Neurobiology of Aging. 25: S496. DOI: 10.1016/S0197-4580(04)81636-1 |
0.65 |
|
2003 |
Mehdi H, Manzi S, Desai P, Chen Q, Nestlerode C, Bontempo F, Strom SC, Zarnegar R, Kamboh MI. A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. European Journal of Biochemistry / Febs. 270: 230-8. PMID 12605674 DOI: 10.1046/J.1432-1033.2003.03379.X |
0.48 |
|
2003 |
Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 116: 98-101. PMID 12497622 DOI: 10.1002/Ajmg.B.10798 |
0.668 |
|
2002 |
Desai P, DeKosky ST, Kamboh MI. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease. Neuroscience Letters. 328: 9-12. PMID 12123847 DOI: 10.1016/S0304-3940(02)00443-3 |
0.695 |
|
2002 |
Desai PP, Bunker CH, Ukoli FA, Kamboh MI. Genetic variation in the apolipoprotein D gene among African blacks and its significance in lipid metabolism. Atherosclerosis. 163: 329-38. PMID 12052480 DOI: 10.1016/S0021-9150(02)00012-6 |
0.566 |
|
2000 |
Ikonomovic MD, Desai PP, Ilyas Kamboh M, Hamilton R, DeKosky ST. Apolipoprotein D distribution in normal and Alzheimer's brains: Implications for its role in the pathogenesis of Alzheimer's disease Neurobiology of Aging. 21: 82. DOI: 10.1016/S0197-4580(00)82591-9 |
0.469 |
|
Show low-probability matches. |